Page last updated: 2024-11-05

tripelennamine and Substance Withdrawal Syndrome

tripelennamine has been researched along with Substance Withdrawal Syndrome in 9 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
"Tripelennamine did not suppress morphine withdrawal signs, but rather aggravated them."1.27Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents. ( Carter, WH; Dewey, WL; Kachur, JF; Tagashira, E, 1984)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19909 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KELLS, P1
Jasinski, DR1
Boren, JJ1
Henningfield, JE1
Johnson, RE1
Lange, WR1
Lukas, SE1
Chasnoff, IJ2
Burns, WJ2
Schnoll, SH2
Tagashira, E1
Kachur, JF1
Carter, WH1
Dewey, WL1
Hatcher, R1
Dunn, DW1
Reynolds, J1
Bhargava, HN1
Showalter, CV1
von Almen, WF1
Miller, JM1

Other Studies

9 other studies available for tripelennamine and Substance Withdrawal Syndrome

ArticleYear
Pyribenzamine as an adjunct in the control of morphine withdrawal syndrome.
    Southern medical journal, 1948, Volume: 41, Issue:2

    Topics: Humans; Morphine; Morphine Dependence; Substance Withdrawal Syndrome; Tripelennamine

1948
Progress report from the NIDA Addiction Research Center, Baltimore, Maryland.
    NIDA research monograph, 1984, Volume: 49

    Topics: Anti-Anxiety Agents; Buprenorphine; Double-Blind Method; Dronabinol; Drug Synergism; Heroin Dependen

1984
Perinatal addiction: the effects of maternal narcotic and nonnarcotic substance abuse on the fetus and neonate.
    NIDA research monograph, 1984, Volume: 49

    Topics: Adult; Arousal; Birth Weight; Female; Heroin Dependence; Humans; Infant, Newborn; Infant, Newborn, D

1984
Pentazocine-tripelennamine ("T's and Blues") substitution studies in morphine-dependent rodents.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 231, Issue:1

    Topics: Animals; Body Weight; Drug Combinations; Humans; Male; Mice; Mice, Inbred ICR; Morphine Dependence;

1984
Pentazocine and tripelennamine ('T's and blue's'): effects on the fetus and neonate.
    Developmental pharmacology and therapeutics, 1983, Volume: 6, Issue:3

    Topics: Adult; Female; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; Methadone; Opioid-Related

1983
Neonatal withdrawal symptoms associated with 'T's and blues' (pentazocine and tripelennamine).
    American journal of diseases of children (1960), 1982, Volume: 136, Issue:7

    Topics: Humans; Infant, Newborn; Infant, Newborn, Diseases; Opium; Pentazocine; Substance Withdrawal Syndrom

1982
Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjects.
    Clinical toxicology, 1981, Volume: 18, Issue:2

    Topics: Animals; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Humans; Lethal Dose 50; Ma

1981
T's and blues. Abuse of pentazocine and tripelennamine.
    JAMA, 1980, Sep-12, Volume: 244, Issue:11

    Topics: Humans; Injections, Intravenous; Methadone; Pentazocine; Substance Withdrawal Syndrome; Substance-Re

1980
"Ts and Blues" in pregnancy.
    The Journal of reproductive medicine, 1986, Volume: 31, Issue:4

    Topics: Adult; Female; Fetal Death; Humans; Infant, Newborn; Infant, Small for Gestational Age; Obstetric La

1986